
Elanco Animal Health Incorporated
Elanco Animal Health Incorporated is a United States-based company in the Healthcare sector with a market capitalisation of $11.8B. Its FinScore is 53/100; its highest-scoring layer is Momentum (60) and its lowest is Value (48).
Share price performance
About Elanco Animal Health Incorporated
www.elanco.comElanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- HQ
- United States
- Fiscal year-end
- December
- Trading currency
- USD
- Reporting currency
- USD
- Fundamentals updated
- 24 days ago
- Market cap
- $11.8B
- Shares outstanding
- 499.4M
- Beta (issuer)
- 1.71
- Revenue (latest FY)
- $4.7B
Revenue breakdown
- Non-US52.6%$2.5B
- UNITED STATES47.4%$2.2B
FinScore
As of 2026-10-19Snapshot
Ownership
As of 2026-06-30Sign up or log in to see Analysis
Analysis for Elanco Animal Health Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Elanco Animal Health Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Elanco Animal Health Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Elanco Animal Health Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Elanco Animal Health Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Elanco Animal Health Incorporated is available to Finryse members. The Overview stays open to everyone; creating an account is free.